13D Filing: SC Fundamental Value Fund, L.P. and Aviragen Therapeutics Inc. (AVIR)

Page 11 of 12

Page 11 of 12 – SEC Filing

CUSIP
No. 053761102
13D/A Page
11 of 11 Pages

SIGNATURE

After reasonable inquiry and
to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated:
January 17, 2018

  SC FUNDAMENTAL
VALUE FUND, L.P.
  By: SC Fundamental
LLC, its General Partner
     
  By: /s/
Neil H. Koffler
  Name: Neil
H. Koffler
  Title:   Member
     
  SC FUNDAMENTAL
LLC
     
  By:  /s/
Neil H. Koffler
  Name: Neil
H. Koffler
  Title:
Member
     
      /s/
Neil H. Koffler
  Neil H. Koffler
as Attorney-in-Fact for
  Peter M.
Collery (1)
   
      /s/
Neil H. Koffler
  Neil H. Koffler
   
      /s/
Neil Koffler
  Neil H. Koffler
as Attorney-in-Fact for
  John T. Bird
(2)
     
      /s/
Neil Koffler
  Neil H. Koffler
as Attorney-in-Fact for
  David A.
Hurwitz (3)
   
  SC FUND MANAGEMENT
PROFIT SHARING PLAN
     
  By: /s/
Peter Collery, its trustee
  Name: Peter
Collery
  Title:
Trustee
(1) Executed
by Neil H. Koffler as Attorney-in-Fact for Peter M. Collery. The Power of Attorney for
Mr. Collery is attached as Exhibit 3 to the Statement on Schedule 13G with respect to
the Common Stock of Trans World Corporation, filed on January 24, 2013, and is incorporated
herein by reference.
     
(2) Executed
by Neil H. Koffler as Attorney-in-Fact for John T. Bird. The Power of Attorney for Mr.
Bird is attached as Exhibit 3 to the Statement on Schedule 13G with respect to the Common
Stock of First Financial Northwest Inc., filed on September 14, 2011, and is incorporated
herein by reference.
     
(3) Executed
by Neil H. Koffler as Attorney-in-Fact for David A. Hurwitz. The Power of Attorney for
Mr. Hurwitz is attached as Exhibit 4 to the Statement on Schedule 13G with respect to
the Common Stock of First Financial Northwest Inc., filed on September 14, 2011, and
is incorporated herein by reference.

 

The
original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If
the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner
of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the
statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated
by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

 

NOTE:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
§240.13d-7 for other parties for whom copies are to be sent.

Follow Vaxart Inc. (NASDAQ:VXRT)

Page 11 of 12